Shakira M Nelson1,2, Orestis A Panagiotou3, Gabriella M Anic2, Alison M Mondul4, Satu Männistö5, Stephanie J Weinstein2, Demetrius Albanes2. 1. Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA shakira.nelson@nih.gov. 2. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 3. Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 4. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA. 5. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Abstract
BACKGROUND: Vitamin D has been discussed in the context of cardiovascular disease, cancer, bone health and other outcomes. Epidemiological studies have reported on the importance of vitamin D in cancer prevention and treatment. The discovery of vitamin D-associated metabolites through agnostic metabolomics analyses offers a new approach for elucidating disease aetiology and health-related pathway identification. METHODS: Baseline serum 25-hydroxy-vitamin D [25(OH)D] and 940 serum metabolites were measured in 392 men from eight nested cancer case-control studies in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish male smokers (aged 50-69 years). The metabolomic profiling was conducted using mass spectrometry. We used linear regression to estimate the standardized beta-coefficient as the effect metric for the associations between metabolites and 25(OH)D levels. RESULTS: A majority of the metabolites associated with 25(OH)D were of lipid origin, including 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) [beta-estimate 0.38 per 1 standard deviation (SD) increment], stearoyl-arachidonoyl-glycerophosphoethanolamine (GPPE) (-0.38 per SD) and two essential fatty acids: eicosapentaenoate (EPA; 0.17 per SD) and docosahexaenoate (DHA; 0.13 per SD). Each of these lipid metabolites was associated with 25(OH)D at the principal components corrected P-value of 3.09 × 10-4 CONCLUSIONS: The large number of metabolites, particularly lipid compounds, found to be associated with serum 25(OH)D provide new biological clues relevant to the role of vitamin D status and human health outcomes. The present findings should be re-examined in other metabolomics studies of diverse populations. Published by Oxford University Press on behalf of the International Epidemiological Association 2016. This work is written by US Government employees and is in the public domain in the United States.
BACKGROUND:Vitamin D has been discussed in the context of cardiovascular disease, cancer, bone health and other outcomes. Epidemiological studies have reported on the importance of vitamin D in cancer prevention and treatment. The discovery of vitamin D-associated metabolites through agnostic metabolomics analyses offers a new approach for elucidating disease aetiology and health-related pathway identification. METHODS: Baseline serum 25-hydroxy-vitamin D [25(OH)D] and 940 serum metabolites were measured in 392 men from eight nested cancer case-control studies in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish male smokers (aged 50-69 years). The metabolomic profiling was conducted using mass spectrometry. We used linear regression to estimate the standardized beta-coefficient as the effect metric for the associations between metabolites and 25(OH)D levels. RESULTS: A majority of the metabolites associated with 25(OH)D were of lipid origin, including 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) [beta-estimate 0.38 per 1 standard deviation (SD) increment], stearoyl-arachidonoyl-glycerophosphoethanolamine (GPPE) (-0.38 per SD) and two essential fatty acids: eicosapentaenoate (EPA; 0.17 per SD) and docosahexaenoate (DHA; 0.13 per SD). Each of these lipid metabolites was associated with 25(OH)D at the principal components corrected P-value of 3.09 × 10-4 CONCLUSIONS: The large number of metabolites, particularly lipid compounds, found to be associated with serum 25(OH)D provide new biological clues relevant to the role of vitamin D status and human health outcomes. The present findings should be re-examined in other metabolomics studies of diverse populations. Published by Oxford University Press on behalf of the International Epidemiological Association 2016. This work is written by US Government employees and is in the public domain in the United States.
Authors: Gabriella M Anic; Demetrius Albanes; Sabine Rohrmann; Norma Kanarek; William G Nelson; Gary Bradwin; Nader Rifai; Katherine A McGlynn; Elizabeth A Platz; Alison M Mondul Journal: Clin Endocrinol (Oxf) Date: 2016-04-06 Impact factor: 3.478
Authors: Mazda Jenab; H Bas Bueno-de-Mesquita; Pietro Ferrari; Franzel J B van Duijnhoven; Teresa Norat; Tobias Pischon; Eugène H J M Jansen; Nadia Slimani; Graham Byrnes; Sabina Rinaldi; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Rudolf Kaaks; Jakob Linseisen; Heiner Boeing; Manuela M Bergmann; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; Franco Berrino; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Martine M Ros; Carla H van Gils; Petra H Peeters; Magritt Brustad; Eiliv Lund; María-José Tormo; Eva Ardanaz; Laudina Rodríguez; Maria-José Sánchez; Miren Dorronsoro; Carlos A Gonzalez; Göran Hallmans; Richard Palmqvist; Andrew Roddam; Timothy J Key; Kay-Tee Khaw; Philippe Autier; Pierre Hainaut; Elio Riboli Journal: BMJ Date: 2010-01-21
Authors: Jessica A Alvarez; Elizabeth Y Chong; Douglas I Walker; Joshua D Chandler; Ellen S Michalski; Ruth E Grossmann; Karan Uppal; Shuzhao Li; Jennifer K Frediani; Rabindra Tirouvanziam; ViLinh T Tran; Vin Tangpricha; Dean P Jones; Thomas R Ziegler Journal: Metabolism Date: 2017-02-11 Impact factor: 8.694
Authors: Kohei Hasegawa; Christopher J Stewart; Juan C Celedón; Jonathan M Mansbach; Courtney Tierney; Carlos A Camargo Journal: Pediatr Allergy Immunol Date: 2018-04-15 Impact factor: 6.377
Authors: Romina di Giuseppe; Manja Koch; Ute Nöthlings; Gabi Kastenmüller; Anna Artati; Jerzy Adamski; Gunnar Jacobs; Wolfgang Lieb Journal: Endocrine Date: 2018-11-17 Impact factor: 3.633
Authors: Bing Yu; Krista A Zanetti; Marinella Temprosa; Demetrius Albanes; Nathan Appel; Clara Barrios Barrera; Yoav Ben-Shlomo; Eric Boerwinkle; Juan P Casas; Clary Clish; Caroline Dale; Abbas Dehghan; Andriy Derkach; A Heather Eliassen; Paul Elliott; Eoin Fahy; Christian Gieger; Marc J Gunter; Sei Harada; Tamara Harris; Deron R Herr; David Herrington; Joel N Hirschhorn; Elise Hoover; Ann W Hsing; Mattias Johansson; Rachel S Kelly; Chin Meng Khoo; Mika Kivimäki; Bruce S Kristal; Claudia Langenberg; Jessica Lasky-Su; Deborah A Lawlor; Luca A Lotta; Massimo Mangino; Loïc Le Marchand; Ewy Mathé; Charles E Matthews; Cristina Menni; Lorelei A Mucci; Rachel Murphy; Matej Oresic; Eric Orwoll; Jennifer Ose; Alexandre C Pereira; Mary C Playdon; Lucilla Poston; Jackie Price; Qibin Qi; Kathryn Rexrode; Adam Risch; Joshua Sampson; Wei Jie Seow; Howard D Sesso; Svati H Shah; Xiao-Ou Shu; Gordon C S Smith; Ulla Sovio; Victoria L Stevens; Rachael Stolzenberg-Solomon; Toru Takebayashi; Therese Tillin; Ruth Travis; Ioanna Tzoulaki; Cornelia M Ulrich; Ramachandran S Vasan; Mukesh Verma; Ying Wang; Nick J Wareham; Andrew Wong; Naji Younes; Hua Zhao; Wei Zheng; Steven C Moore Journal: Am J Epidemiol Date: 2019-06-01 Impact factor: 4.897
Authors: Jessica Lasky-Su; Amber Dahlin; Augusto A Litonjua; Angela J Rogers; Michael J McGeachie; Rebecca M Baron; Lee Gazourian; Diana Barragan-Bradford; Laura E Fredenburgh; Augustine M K Choi; Kris M Mogensen; Sadeq A Quraishi; Karin Amrein; Kenneth B Christopher Journal: Crit Care Date: 2017-07-28 Impact factor: 9.097